765-498-7106
Madrigal Pharmaceuticals shares sharply higher on its liver drug

Madrigal Pharmaceuticals shares sharply higher on its liver drug

Madrigal’s MGL-3196 achieves primary endpoint in Phase 2 clinical trialMadrigal Pharmaceuticals (MDGL) announced positive top-line results from

more
Cannabis in California

Cannabis in California

Names to watch ahead of California marijuana legalizationAs recreational use of marijuana is set to become legal in California on the first day of the

more
Ignyta sold for $1.7 billion

Ignyta sold for $1.7 billion

Roche to acquire Ignyta for $27 per share in cashRoche (RHHBY) and Ignyta (RXDX) announced they have entered into a definitive merger agreement for Ro

more
Brigade Capital takes stake in Kindred, opposes takeover by Humana

Brigade Capital takes stake in Kindred, opposes takeover by Humana

Brigade Capital takes 5.8% stake in Kindred, opposes takeoverBrigade Capital disclosed a 5.8% stake in Kindred Healthcare (KND) and expressed oppositi

more
GlaxoSmithKline and Innoviva report positive data

GlaxoSmithKline and Innoviva report positive data

GSK, Innoviva announce ‘positive’ data in Anoro Ellipta study¬†GlaxoSmithKline (GSK) and Innoviva (INVA) announced positive data from a stu

more
Deciphera Pharmaceuticals is in focus

Deciphera Pharmaceuticals is in focus

Deciphera initiates Phase 3 clinical study of DCC-2618 Deciphera Pharmaceuticals (DCPH) announced that it has initiated a Phase 3 clinical study to ev

more